Pneumonia mortality not improved with empiric anti-MRSA therapy
from Infectious Disease Advisor
Anti-methicillin-resistant Staphylococcus aureus therapy in addition to standard pneumonia therapy does not improve mortality, according to results of a study published in JAMA Internal Medicine. In the United States, the leading cause of death from infection is pneumonia.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063